NPPA revokes its earlier direction refusing discontinuation of GSK's antifungal formulation: Gireesh Babu, New Delhi Saturday ...

The "Pharmaceutical Dissolution Market - A Global and Regional Analysis: Focus on Type, End User, and Region - Analysis and Forecast, 2024-2033" has been added to ResearchAndMarkets.com's offering.

The Immunosuppressants API market offers significant growth potential driven by increasing prevalence of autoimmune diseases ...

Key opportunities in the U.S. pharmaceutical market include growth in specialty drugs and personalized medicine, driven by ...

Deven Choksey is bullish on Alembic Pharmaceutical has recommended buy rating on the stock with a target price of Rs 1,132 in ...

Ahmedabad: Senores Pharma has announced the appointment and categorization of Manohar Lalge, President-Research and Development, as Senior Management Personnel of the Company.Manohar Lalge ...

Pharma leader Sun Pharmaceutical Industries has recorded a Rs 3,118 crore net profit in Q2 FY26, up 2.56 percent, as India ...

Formulation sales in India were Rs 4,734.8 crore, registering a growth of 11%. India Formulation sales accounted for 32.9% of ...

Adhish Patil, CFO of Aarti Drugs, said the company expects export momentum to remain strong in the coming quarters, supported by the ramp-up of two greenfield projects.

The company’s total revenue from operations in Q2FY26 increased nearly 9% to ₹14,478.31 crore from ₹13,291.39 crore, year-on-year (YoY).

Continued advancement toward Phase 2/3 clinical trial initiation, on track for the first half of 2026New preclinical data demonstrated SIL204’s ...